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Introduction and history 
This article highlights many of the issues of concern for analytical scientists working 
in the area of bioanalysis. It draws mainly on topics presented at the Reid 
International Bioanalytical Forum which is a microcosm of the issues faced by 
workers in this field and their attempts to solve them. The Forum was established in 
1975 by the late Dr Eric Reid, Director of the Wolfson Bioanalytical Unit at the 
University of Surrey (see obituary in Bioanalysis (2010) 2(6), 1155). That unit was 
established with addressing the needs of industry and sharing expertise as part of its 
brief. The Forum has run every two years at the University since, the 2011 gathering 
being the 19th. Amongst other things this sharing of expertise amongst practitioners is 
always high on the agenda. It has of course evolved and some of that evolution is 
described here – hopefully not just as an historical account but also based on 
developments in the scientific aspects and the reasons such analysis is so widespread. 
 
From 1975 until 1993 the Forum was run largely by Dr Reid firstly through the 
University and then through Guildford Academic Associates. There was an advisory 
board with a large input from the pharmaceutical industry especially to guide on the 
topics most relevant to that sector. From 1995 until 1999 the Forum was run by Dr 
Reid under the auspices of the Chromatographic Society. In 2001 Dr Reid took a back 
seat and the Forum has operated as The Forum Syndicate of the Chromatographic 
Society and was also named after its originator. 
The proceedings of each meeting were published in a series of books “Methodological 
Surveys in Biochemistry” from the 1975 Forum until the 1997 Forum. The next three 
were published as a special issue in the journal Chromatographia. It is from these 
publications and the more recent programmes that most of the material here is taken. 
This author does not go back to the beginning, indeed the first Forum I attended was 
in 1979 (as a PhD student I would hasten to add) so comments on the early meetings 
are taken entirely from the proceedings. 
There have been some consistent themes throughout the Bioanalytical Forum lifetime.  
Arguably the most valuable one was the encouragement to discuss the “rationale” for 
any particular method rather than just a recipe description. Linked to this was an 
encouragement to discuss approaches that had been tried unsuccessfully as well as the 
solutions. In the early days it was thought there was a lot of “folklore” in laboratories, 
or to put it another way lots of little things that might prevent you getting good results 
that might not be mentioned in mainstream scientific literature. It was basically 
undocumented but successful practices.  
 
Scope 
The term bioanalysis can mean different things to different people. A simple example 
would be measurement of drugs, metabolites and endogenous compounds in 
biological fluids. Another interest group might mean analysis of biologically active 
compounds, whether in biological samples or not. It could also include monitoring 
occupational and environmental exposure to chemicals by determining concentrations 
in biofluids, food, and environmental samples. The meetings have been dominated by 
presentations concerned with accurate measurement of drugs in biological fluids 
mainly plasma/serum, urine. This has been mainly as part of 
phamacokinetic/bioavailablity studies necessary to develop new drugs and provide the 
data for regulatory authority approval. Other areas that occur are determination of 
endogenous compounds and biomarkers, environmental contaminants in animal 
tissues (such as dioxins), forensic toxicology where concentrations tend to be higher 
and therapeutic drug monitoring. One of the conferences did deliberately widen its 
footprint to embrace occupational/environmental samples. This particular meeting 
was centred on sample handling and preparation and so there was an opportunity to 
share expertise from seemingly different problem areas. The common problems 
included;- 
• Measuring at low concentrations 
• Lots of matrix components that might interfere 
• Analytes that might not be stable 
• Proving that your results were reliable 
• Large numbers of samples 
The clientele at the meetings have been dominated by the pharmaceutical industry and 
contract research organisations. There were plenty of academics either looking at new 
areas or techniques development/implementation but they were in the minority. 
 
Techniques 
It is interesting to note the techniques discussed in the first three issues of 
proceedings. HPLC, GC, TLC, luminescence, polarography and immunoassays were 
all reviewed initially along with sample preparation methods. In these early meetings 
there were twice as many contributions from analysts using GC as there were from 
HPLC proponents. Many of the methods involved extraction then derivatisation 
followed by GC. Even in those days mass spectrometry interfaced reasonably well 
with GC (unlike with HPLC) so MS was a common detector along with FID, ECD 
and AFID. In the context of HPLC methods using MS detection barely merited a 
mention. 
There were occasional presentations concerning instrumental development for 
example sensors and biosensors, improvements in detectors such as fluorescence and 
electrochemical. As with many meetings manufacturers were keen to exhibit and to 
present their latest developments. Capillary electrophoresis first got a mention in the 
book from the 1989 Forum. It is still not common at the latest meeting, also true for 
supercritical fluid chromatography. As mentioned earlier many of the presenters were 
actual practitioners from the pharmaceutical industry and their suppliers particularly 
the contract research organisations that carried out much of their bioanalysis for them.  
By the time of the 1997 forum HPLC-MS methods were slightly more predominant 
than HPLC with other detectors. Since then HPLC-MS methods have dominated. It 
was originally thought by many, especially the inexperienced, as the solution to most 
methodological challenges. Of course its own folklore developed – the need to check 
for and overcome ion suppression problems to name but one.  
Automation began to hit the radar in the third symposium and soon after that became 
common place as larger and faster throughput was required. 
 
Analytes 
In the early meetings the vast majority of discussions were about small molecular 
weight drugs and occasionally their metabolites. While there was still plenty of 
methodology for these types of compounds more recent meetings have shown an 
increase in analytes that are of larger molecular mass, peptides, polypeptides, 
oligonucleotides , proteins, antibodies etc. There has also been an increase in 
presentations for analysis of biomarkers reflecting the demand for the industry to 
provide increased proof of therapeutic benefit. For many years the Bioanalytical 
Forum had a major theme as well as encouraging presentations on case histories, 
validation etc. The themes often reflected a drug class particularly important at that 
time. Themes have included antipsychotic, peptides, anti-inflammatory, 
cardiovascular, anti infective, anti allergic, hypolipidaemic, peptide related drugs,  
anti asthmatics, mental alleviators, anti cancer drugs, sample preparation, metabolite 
isolation, enantiomers, molecular imprinting, the mass spec era and metabolic 
syndrome.  
 
Sample preparation/handling 
This was an area that invoked much attention in the early days. Bioanalysts needing to 
reach the low limits of detection required expended a lot of effort preparing samples. 
Liquid –liquid extraction and protein precipitation with organic solvent or strong acid 
were common. Although column chromatography and adsorption onto charcoal were 
also around solid phase extraction as we understand it today was in its infancy. 
Derivatization (because of the predominance of GC) and evaporation of solvents to 
dryness, was common. Despite the advances in instrumentation and the sensitivity 
now achievable for pure compound sample preparation is still necessary for most 
methods to be able to reach the detection levels required in biological samples. These 
of course have lowered which is why some of the expertise described in earlier books 
may be of use even in the mass spec era. Discussions about sources of error in 
bioanalytical methods have often centred on sample preparation. 
 
Quality of results 
Method validation, quality control, sample storage, use of internal standards and 
statistics all get a mention early on. What is clear is that there were few guidelines 
about validation and quality control/assurance. This has changed markedly and much 
time in more recent meetings has been devoted to dialogue with regulators and within 
the fraternity about ensuring reliable results. More details on the exact requirements 
have been forthcoming. 
Great detail in how to conduct stability studies, method validation and monitoring 
method performance are available for example in the book from the 1997 forum.  
This is one area where the motivation of industrial Forum delegates diverges from 
much of academia. In that arena publication in a decent impact factor journal is a 
sufficient endpoint, which in the absence of quality assurance data substantiates very 
little.  
 
Conclusions 
So in the 1970s people worried about the sensitivity of their instruments, the 
reliability of their assays, how much quality control they needed, the stability of their 
samples. Hmm sounds familiar. Many of the issues at the early meetings remain 
issues now; the questions asked are more challenging often at lower concentration, 
with higher throughput required and with greater certainty about the results required. 
Better communication media such as e mail, internet, discussion boards etc. has not 
completely replaced some of the advantages of gathering in an informal environment 
to facilitate detailed discussion of solutions. 
  
